Showing 10 RESULTS FOR
Clinical trials
Commitment to Clinical Trial Diversity
Building an inclusive clinical trials infrastructure is an important step toward combatting health inequities and racial disparities in brain health.
Positive headline results from the Vyepti (eptinezumab-jjmr) RELIEF study
Initiating VYEPTI™ (eptinezumab-jjmr) migraine prevention during a migraine attack demonstrated positive results in the RELIEF study.
Video: How Lundbeck is Utilizing Big Data to Advance Brain Research
Learn how our scientists are using big data to build on our clinical research and advance brain health breakthroughs.
Harnessing the Power of AI to Speed Drug Discovery and Development
Lundbeck and a data-driven drug design company are collaborating to utilize AI to identify clinical candidates for brain disorder therapies.
Lundbeck Initiates Phase II Study of Potential New Treatment of Schizophrenia
Lu AF11167 represents a new approach to treat negative symptoms of schizophrenia, which is currently a huge unmet medical need.